acetylcysteine has been researched along with Mental Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Deest, M; Eberlein, C; Frieling, H; Wieting, J | 1 |
| Green, R; Ooi, SL; Pak, SC | 1 |
| Berk, M; Dean, OM; Goldstein, S; Samuni, Y | 1 |
| Cooper, JG; Teo, AI | 1 |
| Berk, M; Dean, O; Delhey, L; Frye, R; Kumar, N; Slattery, J; Spielholz, C | 1 |
| Racz, R; Sohoni, P; Sweet, BV | 1 |
| Dowling, NA; Lorains, FK; Merkouris, SS | 1 |
| Davis, MC; Kruse, JL; Monsivais, SR; Wisdom, N | 1 |
| Ferrari, S; Galeazzi, GM; Galletti, M; Giambalvo, N; Minarini, A; Perrone, D; Rioli, G | 1 |
| Baker, NL; Cloud, K; Gray, KM; Killeen, TK; McRae-Clark, AL; Sherman, BJ; Sonne, SC | 1 |
| Easter, JS; Ganetsky, M; Kimlin, EJ | 1 |
| Berk, M; Dean, O; Giorlando, F | 1 |
| Crum, WR; Johansson, SM; Modo, M; Vernon, AC | 1 |
| Caflisch, C; Herdener, M; Oppliger, R; Stohler, R | 1 |
| Goldstein, BI | 1 |
| Berk, M; Dean, OM; Gray, LJ; Malhi, GS | 1 |
9 review(s) available for acetylcysteine and Mental Disorders
| Article | Year |
|---|---|
N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence.
Topics: Acetylcysteine; Administration, Oral; Humans; Mental Disorders | 2018 |
The chemistry and biological activities of N-acetylcysteine.
Topics: Acetylcysteine; Animals; Apoptosis; Blood-Brain Barrier; Cell Cycle; Cell Membrane; Humans; Mental Disorders; Signal Transduction | 2013 |
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Topics: Acetylcysteine; Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Male; Mental Disorders; Nervous System Diseases; Neurology; Psychiatry; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2015 |
Oral acetylcysteine for neuropsychiatric disorders.
Topics: Acetylcysteine; Administration, Oral; Autistic Disorder; Bipolar Disorder; Complementary Therapies; Dietary Supplements; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Schizophrenia; Trichotillomania | 2015 |
Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research.
Topics: Acetylcysteine; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Bipolar Disorder; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Free Radical Scavengers; Gambling; Humans; Lithium Compounds; Mental Disorders; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Tobacco Use Disorder | 2016 |
N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
Topics: Acetylcysteine; Animals; Antioxidants; Free Radical Scavengers; Glutathione; Humans; Mental Disorders | 2017 |
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.
Topics: Acetylcysteine; Humans; Mental Disorders | 2011 |
[Treating cocaine addiction].
Topics: Acetylcysteine; Alcohol Deterrents; Baclofen; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine-Related Disorders; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Disulfiram; Free Radical Scavengers; Humans; Mental Disorders; Methylphenidate; Modafinil; Muscle Relaxants, Central; Psychotherapy; Switzerland | 2012 |
The promise of N-acetylcysteine in neuropsychiatry.
Topics: Acetylcysteine; Animals; Humans; Mental Disorders | 2013 |
1 trial(s) available for acetylcysteine and Mental Disorders
| Article | Year |
|---|---|
Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.
Topics: Acetylcysteine; Adult; Cannabinoids; Comorbidity; Female; Free Radical Scavengers; Help-Seeking Behavior; Humans; Male; Marijuana Abuse; Mental Disorders; Middle Aged; Patient Acceptance of Health Care; Patient Care Management; Sex Factors; Substance Withdrawal Syndrome | 2017 |
6 other study(ies) available for acetylcysteine and Mental Disorders
| Article | Year |
|---|---|
N-Acetylcysteine provides limited efficacy as treatment option for skin picking in Prader-Willi syndrome.
Topics: Acetylcysteine; Female; Humans; Male; Mental Disorders; Prader-Willi Syndrome; Retrospective Studies; Self-Injurious Behavior | 2022 |
The epidemiology and management of adult poisonings admitted to the short-stay ward of a large Scottish emergency department.
Topics: Acetaminophen; Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Antidotes; Central Nervous System Depressants; Charcoal; Drug Overdose; Emergency Service, Hospital; Ethanol; Female; Follow-Up Studies; Free Radical Scavengers; Hospitalization; Humans; Length of Stay; Male; Mental Disorders; Middle Aged; Naloxone; Narcotic Antagonists; Patient Admission; Patient Discharge; Public Health; Retrospective Studies; Scotland; Self-Injurious Behavior | 2013 |
N-Acetylcysteine Supplementation in an Individual With Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Psychosis.
Topics: Acetylcysteine; Adult; Free Radical Scavengers; Glucosephosphate Dehydrogenase Deficiency; Humans; Male; Mental Disorders | 2016 |
A 46-year-old woman with altered mental status and garbled speech.
Topics: Acetaminophen; Acetylcysteine; Diagnosis, Differential; Diphenhydramine; Electrocardiography; Female; Humans; Mental Disorders; Middle Aged; Poisoning; Speech Disorders; Spinal Puncture; Tomography, X-Ray Computed | 2009 |
Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease.
Topics: Acetylcysteine; Animals; Behavior, Animal; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Disease Progression; Male; Mental Disorders; Motor Activity; Parkinson Disease, Secondary; Prognosis; Proteasome Inhibitors; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2011 |
In this issue/abstract thinking: NAC attack: is N-acetylcysteine ready for prime time in child and adolescent psychiatry?
Topics: Acetylcysteine; Adolescent; Adolescent Psychiatry; Child; Child Psychiatry; Humans; Mental Disorders; Psychotherapy; Psychotropic Drugs | 2013 |